Research location
Leominster
Massachusetts, United States
Advertisement
Research activity in Leominster
Massachusetts, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 8 trials and 8 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Leominster
8 linked trials · page 1 of 1Precision Event Monitoring for Patients With Heart Failure Using HeartLogicNCT03579641 · 2018-06-01 · 1 site observation
COMPLETED
Optisure Lead Post Approval StudyNCT02235545 · 2014-08-01 · 1 site observation
TERMINATED
A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or PlaceboNCT01359150 · 2011-09-01 · 1 site observation
COMPLETED
A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis MedicationsNCT00856544 · 2009-05-01 · 1 site observation
COMPLETED
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast CancerNCT00382070 · 2006-08-01 · 1 site observation
UNKNOWN
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)NCT00310180 · 2006-04-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast CancerNCT00087178 · 2004-05-01 · 1 site observation
COMPLETED
Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye SyndromeNCT00025818 · 2001-05-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.